首页> 中文期刊> 《浙江临床医学》 >直接冠状动脉内支架置入治疗急性心肌梗塞31例临床报告

直接冠状动脉内支架置入治疗急性心肌梗塞31例临床报告

         

摘要

Objective To evaluate the efficacyand safety of primary intracoronary stenting in acute myocardial infarction(AMI).Methods 31 AMI patients(24 males and 7 females, mean age 64.9 years) who underwent primary intracoronary stenting were analyzed. Results After operation, all 31 patients' blood flow wer successfully restored from TIMI 0 grade to TIMI 3 grade. Residual stenosis decreased to 5%~10% . No death occurred amgong the 9 patients whose age was over 70. Among the 6patients with cardiogenic shock, only one patient had irreversible heart failure and died. During the 1~21 monhts follow-up period of the other 30 patients, no death or heart event happened. Conclusion Primary intracornary stenting was an efficient therapeutic procedure to AMI patients, especially to those with high risks.%目的探讨直接冠状动脉内支架治疗急性心肌梗塞的疗效和安全性。方法对31例急性心肌梗塞(AMI)行直接冠状动脉内支架置入病例进行分析。其中男24例,女7例,平均年龄为64.9岁。结果31例患者术前梗塞相关血管均为TIMI0级血流,经置入冠脉内支架后梗塞相关血管均恢复TIMIⅢ级,残余狭窄为5%~10%,血管开通率为100%。9例年龄超过70岁患者无一死亡,并且没发生严重的并发症;6例心源性休克除1例心源性休克不可逆转而发生电机械分离抢救无效死亡外,其余5例顺利恢复。30例患者在1~21月随访中均未发生死亡,无心脏事件发生。结论冠脉内支架置入是治疗急性心肌梗塞安全有效的方法,能明显降低高危患者的死亡率。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号